SEATTLE--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive diagnostics technology released this morning an overview of its Form 10-K annual report for its fiscal year ending ...

CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...

Waiting on Apple to add glucose tracking on a smartwatch to learn about your blood sugar? Don't. Try a biosensor instead.

Know Labs, Inc. (NYSE American: KNW), leading developer of non-invasive diagnostics technology, today announced that, as previously disclosed in its Annual Report on Form 10-K for the year ended ...

In recent years, technological advancements in healthcare have revolutionised the management of chronic conditions like ...

FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the fourth quarter and fiscal ...

“An average is not a very good way of measuring what is your control,” he said. “When you have those big excursions of highs ...

Oura CEO Tom Hale spoke to CNBC about the smart ring product category and the impact of Samsung’s entrance into the space.

Dr Jagadish J Hiremath, public health intellectual, mentions, “Continuous Glucose Monitors (CGMs) are devices that provide real-time glucose readings.” ...

A novel system combining high-speed video and AI algorithms could revolutionize health screenings for high blood pressure and ...

Wearable devices are the next big leap in the prevention and treatment of breast cancer through early detection and ...